Clinical Trials Logo

Keratoconus clinical trials

View clinical trials related to Keratoconus.

Filter by:

NCT ID: NCT03220529 Completed - Keratoconus Clinical Trials

A Study to Test the Potential of Brillouin Microscopy for Biomechanical Properties Measurements in Human Cornea

Start date: November 2016
Phase: N/A
Study type: Interventional

The purpose of this research study is to find out if the new Brillouin Ocular Scanner can measure the variation (difference) of the corneal elastic changes involved in the onset of corneal ectasia, induced by LASIK surgery and cornea collagen crosslinking (CXL) treatment. Ectasia refers to the thinning and bulging of the cornea and results in severe vision degradation (loss), which may occur because of a progressive disease (keratoconus) or because of LASIK surgery. It is believed that the structural weakening of the cornea plays a major role in developing ectasia. CXL is a treatment that is able to halt the progression of ectasia. The Brillouin Ocular Scanner is a technique based on the principles used in the laser speed measuring of a car (radar gun). When laser light illuminates a moving sample, a portion of the light slightly changes color. In our body, e.g in eye and corneal tissue, very weak sound waves are naturally present and they can induce a similar color shift. Measuring this color shift with a sensitive light color meter (spectrometer), we will measure the sound speed in the tissue.

NCT ID: NCT03187912 Completed - Keratoconus Clinical Trials

Accelerated Corneal Cross-linking With Different Riboflavin Solutions

Start date: September 19, 2016
Phase: Phase 3
Study type: Interventional

Following the Bunsen-Roscoe law, accelerated cross-linking protocols with higher irradiation intensities and shorter irradiation times have been introduced. In addition, new riboflavin solutions with HPMC (hydroxylpropyl methylcellulose) instead of dextran found its way into CXL-treatment. The aim of this trial is to evaluate clinical outcomes in an accelerated corneal collagen cross-linking protocol with different riboflavin solutions.

NCT ID: NCT03184610 Completed - Keratoconus Clinical Trials

Distinguishing Healthy and Keratoconic Eyes Using Ultrahigh-Resolution OCT

Start date: December 2014
Phase: N/A
Study type: Observational

The OCT used in this trial offers the advantage of both a non-contact method and a very high axial resolution. Determined parameters with the highest potential of diagnostic discrimination between eyes with Keratoconus and healthy eyes are investigated. Aim of this trial is to investigate differences of specific parameters of epithelium thickness maps at healthy eyes and eyes with Keratoconus.

NCT ID: NCT03127163 Completed - Keratoconus Clinical Trials

Intraestromal Corneal Ring in Mild Keratoconus

Start date: January 10, 2015
Phase: N/A
Study type: Interventional

To determine whether the implantation of an intrastromal corneal ring is an effective treatment for a homogeneous group of mild keratoconus patients.

NCT ID: NCT03091101 Completed - Keratoconus Clinical Trials

Impact of Scleral Contact Lens Wear on Corneal Nerves in Keratoconus

Start date: March 15, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate changes in corneal innervation during scleral contact lens wear in a keratoconic population. Specifically, changes in corneal sensitivity and nerve fiber density from baseline in the central and mid-peripheral corneal locations will be measured over a 6-month lens wear period. An additional aim of the study is to investigate the impact of scleral lens wear on corneal inflammation within the same study group. This will be achieved by comparing dendritic cell density change from baseline over the study period.

NCT ID: NCT03071302 Completed - Keratoconus Clinical Trials

Evaluation of Tomographic and Genetic Aspects of Keratoconus Patients Compared to Sounds Corneas

Start date: August 1, 2015
Phase: N/A
Study type: Interventional

Evaluation of tomographic (Pentacam) parameters and genetic parameters of Visual System Homeobox 1 (VSX1), Superoxide Dismutase (SOD1), Tissue Inhibitors of Metalloproteinases (TIMP3) genes of keratoconus patients diagnosed by clinical exam and topographic pattern. Basically we are screening patients that don't have keratoconus that those have keratoconus. The pentacam index of corneal curvature, thinnest point, corneal high order aberrations, posterior and anterior elevation, corneal densitometry, corneal volume were investigated. To analyze the genes, we took corneal epithelium samples of patients submitted to cross linking compared to (PRK) Photo Refractive Keratectomy ones. Also will be evaluated the genes of peripheral blood.

NCT ID: NCT02979054 Completed - Keratoconus Clinical Trials

Performance and Safety Assessment of T4020 in Managing Corneal Epithelial Defect Following Epi-off Accelerated Crosslinking

Start date: December 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the performance and safety of T4020 versus saline solution.

NCT ID: NCT02891655 Completed - Keratoconus Clinical Trials

KERatoconus and Metalloproteinases InvesTigation

KERMIT
Start date: December 2, 2016
Phase:
Study type: Observational

Corneal stromal thinning observed in keratoconic eyes could result from an increased synthesis of MMP at the level of the anterior stroma and the corneal epithelium induced by an overexpression of the Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) and Galectin-3 by epithelial cells. A differential expression of EMMPRIN, Galectin-3 and metalloproteinases (MMP) may be observed between the apex of the keratoconus and the peripheral cornea. Highlighting the implication of EMMPRIN and Galectin-3 could lead to the development of specific inhibitors to slow or to stop keratoconus evolution.

NCT ID: NCT02883881 Completed - Keratoconus Clinical Trials

Correlation Between Eye Rubbing and Keratoconus Severity in a Treatment-naive Keratoconic Population

FROTT EYES
Start date: October 2015
Phase: N/A
Study type: Observational

determination if, within a keratoconic population, strong eye rubbing was correlated with visual acuity, spherical equivalent value, biomicroscopic signs, corneal pachymetry, keratometry, and tomography classification determinating keratoconus stage.

NCT ID: NCT02883868 Completed - Clinical trials for Progressive Keratoconus

Stromal Demarcation Line: is it Predictive for Cross-Linking Efficiency?

STROMA-CROSS
Start date: October 2015
Phase: N/A
Study type: Observational

To assess the association between stromal demarcation line after collagen crosslinking (CXL) for progressive keratoconus and mid-term (6 month) refractive, topographic and clinical outcomes of CXL